Clinical Trial Update: Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GSK1437173A herpes zoster vaccine in HIV-infected adults; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Shingrix (recombinant zoster vaccine, adjuvanted)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07